Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 404 entries
Sorted by: Best Match Show Resources per page
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.

Frontiers in endocrinology

De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U.
PMID: 31191451
Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019.

Testicular cancer is the most common tumor in young males aged 15-40 years. The overall cure rate for men with testicular cancer is >90%, so a huge number of these patients will become testicular cancer survivors. These people may...

Cite
De Padova S, Casadei C, Berardi A, et al. Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support. Front Endocrinol (Lausanne). 2019;10:318doi: 10.3389/fendo.2019.00318.
De Padova, S., Casadei, C., Berardi, A., Bertelli, T., Filograna, A., Cursano, M. C., Menna, C., Burgio, S. L., Altavilla, A., Schepisi, G., Prati, S., Montalti, S., Chovanec, M., Banna, G. L., Grassi, L., Mego, M., & De Giorgi, U. (2019). Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support. Frontiers in endocrinology, 10318. https://doi.org/10.3389/fendo.2019.00318
De Padova, Silvia, et al. "Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support." Frontiers in endocrinology vol. 10 (2019): 318. doi: https://doi.org/10.3389/fendo.2019.00318
De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U. Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support. Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019. PMID: 31191451; PMCID: PMC6546807.
Copy Download .nbib Format: NLM
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?.

Translational lung cancer research

Addeo A, Banna GL.
PMID: 30393623
Transl Lung Cancer Res. 2018 Sep;7:S283-S286. doi: 10.21037/tlcr.2018.07.10.

No abstract available.

Cite
Addeo A, Banna GL. PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Transl Lung Cancer Res. 2018;7:S283-S286doi: 10.21037/tlcr.2018.07.10.
Addeo, A., & Banna, G. L. (2018). PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Translational lung cancer research, 7S283-S286. https://doi.org/10.21037/tlcr.2018.07.10
Addeo, Alfredo, and Banna, Giuseppe Luigi. "PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?." Translational lung cancer research vol. 7 (2018): S283-S286. doi: https://doi.org/10.21037/tlcr.2018.07.10
Addeo A, Banna GL. PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Transl Lung Cancer Res. 2018 Sep;7:S283-S286. doi: 10.21037/tlcr.2018.07.10. PMID: 30393623; PMCID: PMC6193909.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in pharmacology

Banna GL, Torino F, Marletta F, Santagati M, Salemi R, Cannarozzo E, Falzone L, Ferraù F, Libra M.
PMID: 28919861
Front Pharmacol. 2017 Sep 01;8:603. doi: 10.3389/fphar.2017.00603. eCollection 2017.

Cancer is the second leading cause of death in the western world. In the era of precision medicine, a significant number of cancer patients can be cured with several anti-cancer therapeutic regimens. However, therapy failure may be caused by...

Cite
Banna GL, Torino F, Marletta F, et al. . Front Pharmacol. 2017;8:603doi: 10.3389/fphar.2017.00603.
Banna, G. L., Torino, F., Marletta, F., Santagati, M., Salemi, R., Cannarozzo, E., Falzone, L., Ferraù, F., & Libra, M. (2017). . Frontiers in pharmacology, 8603. https://doi.org/10.3389/fphar.2017.00603
Banna, Giuseppe L, et al. "." Frontiers in pharmacology vol. 8 (2017): 603. doi: https://doi.org/10.3389/fphar.2017.00603
Banna GL, Torino F, Marletta F, Santagati M, Salemi R, Cannarozzo E, Falzone L, Ferraù F, Libra M. . Front Pharmacol. 2017 Sep 01;8:603. doi: 10.3389/fphar.2017.00603. eCollection 2017. PMID: 28919861; PMCID: PMC5585742.
Copy Download .nbib Format: NLM
From Systematic Review to Call for Action.

Hispanic health care international : the official journal of the National Association of Hispanic Nurses

Sawin EM, Sobel LL, Annan SL, Schminkey DL.
PMID: 28558498
Hisp Health Care Int. 2017 Jun;15(2):79-87. doi: 10.1177/1540415317698947. Epub 2017 Apr 09.

INTRODUCTION: Intimate partner violence (IPV) is a global public health and criminal justice concern with significant impacts; especially high rates are seen among rural Hispanic American (HA) communities, the fastest growing population in the United States. They experience additional...

Cite
Sawin EM, Sobel LL, Annan SL, et al. From Systematic Review to Call for Action. Hisp Health Care Int. 2017;15(2):79-87doi: 10.1177/1540415317698947.
Sawin, E. M., Sobel, L. L., Annan, S. L., & Schminkey, D. L. (2017). From Systematic Review to Call for Action. Hispanic health care international : the official journal of the National Association of Hispanic Nurses, 15(2), 79-87. https://doi.org/10.1177/1540415317698947
Sawin, Erika Metzler, et al. "From Systematic Review to Call for Action." Hispanic health care international : the official journal of the National Association of Hispanic Nurses vol. 15,2 (2017): 79-87. doi: https://doi.org/10.1177/1540415317698947
Sawin EM, Sobel LL, Annan SL, Schminkey DL. From Systematic Review to Call for Action. Hisp Health Care Int. 2017 Jun;15(2):79-87. doi: 10.1177/1540415317698947. Epub 2017 Apr 09. PMID: 28558498.
Copy Download .nbib Format: NLM
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.

The World Allergy Organization journal

Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, Bozzola M, Bradsher J, Compalati E, Ebisawa M, Guzman MA, Li H, Heine RG, Keith P, Lack G, Landi M, Martelli A, Rancé F, Sampson H, Stein A, Terracciano L, Vieths S.
PMID: 23268426
World Allergy Organ J. 2010 Apr;3(4):57-161. doi: 10.1097/WOX.0b013e3181defeb9. Epub 2010 Apr 23.

No abstract available.

Cite
Fiocchi A, Brozek J, Schünemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J. 2010;3(4):57-161doi: 10.1097/WOX.0b013e3181defeb9.
Fiocchi, A., Brozek, J., Schünemann, H., Bahna, S. L., von Berg, A., Beyer, K., Bozzola, M., Bradsher, J., Compalati, E., Ebisawa, M., Guzman, M. A., Li, H., Heine, R. G., Keith, P., Lack, G., Landi, M., Martelli, A., Rancé, F., Sampson, H., Stein, A., Terracciano, L., & Vieths, S. (2010). World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. The World Allergy Organization journal, 3(4), 57-161. https://doi.org/10.1097/WOX.0b013e3181defeb9
Fiocchi, Alessandro, et al. "World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines." The World Allergy Organization journal vol. 3,4 (2010): 57-161. doi: https://doi.org/10.1097/WOX.0b013e3181defeb9
Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, Bozzola M, Bradsher J, Compalati E, Ebisawa M, Guzman MA, Li H, Heine RG, Keith P, Lack G, Landi M, Martelli A, Rancé F, Sampson H, Stein A, Terracciano L, Vieths S. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J. 2010 Apr;3(4):57-161. doi: 10.1097/WOX.0b013e3181defeb9. Epub 2010 Apr 23. PMID: 23268426; PMCID: PMC3488907.
Copy Download .nbib Format: NLM
Mixed connective tissue disease: the King Faisal Specialist Hospital experience.

Annals of Saudi medicine

Rayes HA, Al-Sheikh A, Al Dalaan A, Al Saleh S.
PMID: 17259766
Ann Saudi Med. 2002 Jan-Mar;22(1):43-6. doi: 10.5144/0256-4947.2002.43.

BACKGROUND: The aim of this study was to assess the clinical presentation, complications and serological analysis of mixed connective tissue disease (MCTD) at King Faisal Specialist Hospital & Research Centre (KFSH&RC), and to determine the long-term clinical and immunologic...

Cite
Rayes HA, Al-Sheikh A, Al Dalaan A, et al. Mixed connective tissue disease: the King Faisal Specialist Hospital experience. Ann Saudi Med. 2002;22(1):43-6doi: 10.5144/0256-4947.2002.43.
Rayes, H. A., Al-Sheikh, A., Al Dalaan, A., & Al Saleh, S. (2002). Mixed connective tissue disease: the King Faisal Specialist Hospital experience. Annals of Saudi medicine, 22(1), 43-6. https://doi.org/10.5144/0256-4947.2002.43
Rayes, Hanan Al, et al. "Mixed connective tissue disease: the King Faisal Specialist Hospital experience." Annals of Saudi medicine vol. 22,1 (2002): 43-6. doi: https://doi.org/10.5144/0256-4947.2002.43
Rayes HA, Al-Sheikh A, Al Dalaan A, Al Saleh S. Mixed connective tissue disease: the King Faisal Specialist Hospital experience. Ann Saudi Med. 2002 Jan-Mar;22(1):43-6. doi: 10.5144/0256-4947.2002.43. PMID: 17259766.
Copy Download .nbib Format: NLM
Food allergy: manifestations, diagnosis and management.

Expert review of clinical immunology

Bahna SL, Mayer CW.
PMID: 20477661
Expert Rev Clin Immunol. 2005 May;1(1):133-43. doi: 10.1586/1744666X.1.1.133.

Adverse reactions to food are common but only a fraction of them are due to hypersensitivity (or allergy). Of the latter, immunoglobulin (Ig)E-mediated reactions appear to be the most common and best understood. A wide variety of manifestations may...

Cite
Bahna SL, Mayer CW. Food allergy: manifestations, diagnosis and management. Expert Rev Clin Immunol. 2005;1(1):133-43doi: 10.1586/1744666X.1.1.133.
Bahna, S. L., & Mayer, C. W. (2005). Food allergy: manifestations, diagnosis and management. Expert review of clinical immunology, 1(1), 133-43. https://doi.org/10.1586/1744666X.1.1.133
Bahna, Sami L, and Mayer, Chad W. "Food allergy: manifestations, diagnosis and management." Expert review of clinical immunology vol. 1,1 (2005): 133-43. doi: https://doi.org/10.1586/1744666X.1.1.133
Bahna SL, Mayer CW. Food allergy: manifestations, diagnosis and management. Expert Rev Clin Immunol. 2005 May;1(1):133-43. doi: 10.1586/1744666X.1.1.133. PMID: 20477661.
Copy Download .nbib Format: NLM
Can integrative weaning index be a routine predictor for weaning success?.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

El-Baradey GF, El-Shmaa NS, Ganna SA.
PMID: 26816445
Indian J Crit Care Med. 2015 Dec;19(12):703-7. doi: 10.4103/0972-5229.171352.

OBJECTIVE: To assess the effectiveness of integrative weaning index (IWI) as a predictor of weaning success.MATERIALS AND METHODS: This is a prospective randomized controlled observer-blinded study and carried out on 120 patients of both sexes; patients who received mechanical...

Cite
El-Baradey GF, El-Shmaa NS, Ganna SA. Can integrative weaning index be a routine predictor for weaning success?. Indian J Crit Care Med. 2015;19(12):703-7doi: 10.4103/0972-5229.171352.
El-Baradey, G. F., El-Shmaa, N. S., & Ganna, S. A. (2015). Can integrative weaning index be a routine predictor for weaning success?. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 19(12), 703-7. https://doi.org/10.4103/0972-5229.171352
El-Baradey, Ghada F, et al. "Can integrative weaning index be a routine predictor for weaning success?." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 19,12 (2015): 703-7. doi: https://doi.org/10.4103/0972-5229.171352
El-Baradey GF, El-Shmaa NS, Ganna SA. Can integrative weaning index be a routine predictor for weaning success?. Indian J Crit Care Med. 2015 Dec;19(12):703-7. doi: 10.4103/0972-5229.171352. PMID: 26816445; PMCID: PMC4711201.
Copy Download .nbib Format: NLM
An integrative review of student evaluations of teaching: implications for evaluation of nursing faculty.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing

Annan SL, Tratnack S, Rubenstein C, Metzler-Sawin E, Hulton L.
PMID: 24075267
J Prof Nurs. 2013 Sep-Oct;29(5):e10-24. doi: 10.1016/j.profnurs.2013.06.004.

Student evaluations of teaching often play an important role in the promotion and tenure of faculty. Many of the instruments in use within the university setting are self-developed and have not undergone psychometric testing. More specifically, nursing education has...

Cite
Annan SL, Tratnack S, Rubenstein C, et al. An integrative review of student evaluations of teaching: implications for evaluation of nursing faculty. J Prof Nurs. 2013;29(5):e10-24doi: 10.1016/j.profnurs.2013.06.004.
Annan, S. L., Tratnack, S., Rubenstein, C., Metzler-Sawin, E., & Hulton, L. (2013). An integrative review of student evaluations of teaching: implications for evaluation of nursing faculty. Journal of professional nursing : official journal of the American Association of Colleges of Nursing, 29(5), e10-24. https://doi.org/10.1016/j.profnurs.2013.06.004
Annan, Sandra L, et al. "An integrative review of student evaluations of teaching: implications for evaluation of nursing faculty." Journal of professional nursing : official journal of the American Association of Colleges of Nursing vol. 29,5 (2013): e10-24. doi: https://doi.org/10.1016/j.profnurs.2013.06.004
Annan SL, Tratnack S, Rubenstein C, Metzler-Sawin E, Hulton L. An integrative review of student evaluations of teaching: implications for evaluation of nursing faculty. J Prof Nurs. 2013 Sep-Oct;29(5):e10-24. doi: 10.1016/j.profnurs.2013.06.004. PMID: 24075267.
Copy Download .nbib Format: NLM
KRAS G12C Mutations in NSCLC: From Target to Resistance.

Cancers

Addeo A, Banna GL, Friedlaender A.
PMID: 34064232
Cancers (Basel). 2021 May 21;13(11). doi: 10.3390/cancers13112541.

Lung cancer represents the most common form of cancer, accounting for 1.8 million deaths globally in 2020. Over the last decade the treatment for advanced and metastatic non-small cell lung cancer have dramatically improved largely thanks to the emergence...

Cite
Addeo A, Banna GL, Friedlaender A. KRAS G12C Mutations in NSCLC: From Target to Resistance. Cancers (Basel). 2021;13(11)doi: 10.3390/cancers13112541.
Addeo, A., Banna, G. L., & Friedlaender, A. (2021). KRAS G12C Mutations in NSCLC: From Target to Resistance. Cancers, 13(11), . https://doi.org/10.3390/cancers13112541
Addeo, Alfredo, et al. "KRAS G12C Mutations in NSCLC: From Target to Resistance." Cancers vol. 13,11 (2021). doi: https://doi.org/10.3390/cancers13112541
Addeo A, Banna GL, Friedlaender A. KRAS G12C Mutations in NSCLC: From Target to Resistance. Cancers (Basel). 2021 May 21;13(11). doi: 10.3390/cancers13112541. PMID: 34064232; PMCID: PMC8196854.
Copy Download .nbib Format: NLM
Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ.

Mucosal immunology

Van Der Kraak LA, Schneider C, Dang V, Burr AHP, Weiss ES, Varghese JA, Yang L, Hand TW, Canna SW.
PMID: 34103660
Mucosal Immunol. 2021 Sep;14(5):1100-1112. doi: 10.1038/s41385-021-00419-1. Epub 2021 Jun 08.

Major histocompatibility complex class II (MHCII) is dynamically expressed on intestinal epithelial cells (IECs) throughout the intestine, but its regulation remains poorly understood. We observed that spontaneous upregulation of IEC MHCII in locally bred Rag1

Cite
Van Der Kraak LA, Schneider C, Dang V, et al. Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ. Mucosal Immunol. 2021;14(5):1100-1112doi: 10.1038/s41385-021-00419-1.
Van Der Kraak, L. A., Schneider, C., Dang, V., Burr, A. H. P., Weiss, E. S., Varghese, J. A., Yang, L., Hand, T. W., & Canna, S. W. (2021). Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ. Mucosal immunology, 14(5), 1100-1112. https://doi.org/10.1038/s41385-021-00419-1
Van Der Kraak, L A, et al. "Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ." Mucosal immunology vol. 14,5 (2021): 1100-1112. doi: https://doi.org/10.1038/s41385-021-00419-1
Van Der Kraak LA, Schneider C, Dang V, Burr AHP, Weiss ES, Varghese JA, Yang L, Hand TW, Canna SW. Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ. Mucosal Immunol. 2021 Sep;14(5):1100-1112. doi: 10.1038/s41385-021-00419-1. Epub 2021 Jun 08. PMID: 34103660; PMCID: PMC8562907.
Copy Download .nbib Format: NLM
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm.

Oncology reviews

Banna GL, Cantale O, Bersanelli M, Del Re M, Friedlaender A, Cortellini A, Addeo A.
PMID: 32782728
Oncol Rev. 2020 Jul 21;14(2):490. doi: 10.4081/oncol.2020.490. eCollection 2020 Jul 06.

Anti-PD1 and anti-PD-L1 agents may have intrinsic and clinically relevant differences in the treatment of non-small cell lung cancer (NSCLC) patients. By reviewing currently available indirect evidence on these agents for NSCLC treatment, highlighting possible inter- and intra-class dissimilarities,...

Cite
Banna GL, Cantale O, Bersanelli M, et al. Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm. Oncol Rev. 2020;14(2):490doi: 10.4081/oncol.2020.490.
Banna, G. L., Cantale, O., Bersanelli, M., Del Re, M., Friedlaender, A., Cortellini, A., & Addeo, A. (2020). Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm. Oncology reviews, 14(2), 490. https://doi.org/10.4081/oncol.2020.490
Banna, Giuseppe Luigi, et al. "Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm." Oncology reviews vol. 14,2 (2020): 490. doi: https://doi.org/10.4081/oncol.2020.490
Banna GL, Cantale O, Bersanelli M, Del Re M, Friedlaender A, Cortellini A, Addeo A. Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm. Oncol Rev. 2020 Jul 21;14(2):490. doi: 10.4081/oncol.2020.490. eCollection 2020 Jul 06. PMID: 32782728; PMCID: PMC7385529.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 404 entries